Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
1.4%
1w
0.1%
1m
5.3%
3m
1.5%
6m
8.2%
1y
29.9%
5y
18.8%
10y
25.2%
all
28.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 28,638 1.4%
26,926
29,780
Company Overview

Sales
6,066 Cr
Growth: 7.2%
Profit after Tax
1,285 Cr
Growth: 3.7%
Large Cap
60,853 Cr
P/E: 47.4x
Industry P/E: 37.3x
Fundamentals

Sales (Cr) ₹ 6,066
Growth 7.2%
EBITDA 25.5%
P/S 10.0x
Dividend 0.8%
P/E 47.4x
Book Value ₹ 2,064
PEG Ratio 6.6x
ROE 31.7%
P/B 13.9x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.Products and Services offered by the companyCardiovascular- Keeping heart healthy with breakthrough medical technologies.Diabetes- Helping people with diabetes enjoy healthier, active lives.
Investors (50)
Followers (16)